Histogen (HSTO) to Explore Strategic Alternatives

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. BAC
2. DPZ
3. NVDA
4. ACI
5. DRS
6. GS
7. JPM
8. AVAV
9. META
10. VSTM

Go back to Histogen (HSTO) to Explore Strategic Alternatives

Histogen to Explore Strategic Alternatives

July 5, 2023 4:05 PM EDT

SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the bodys natural process to restore immune function, today announced that it has completed a review of its business, including the status of programs, resources and capabilities, and has decided to pause further development of its programs and commence a process to explore strategic alternatives with the intent to enhance shareholder value. Histogen has engaged Roth Capital... More